Mammalian peptide antibiotics as regulatory and anticancer agents

Experimental Oncology

Volumn 20, Issue 3-4, 1998, Pages 170-179

  Hobta, A I ^a   Pogrebnoy, P V ^a  

^a R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

Author keywords

Antibiotic peptides; Anticancer agents; Growth regulation; Inflammation; Kinase inhibitors

Indexed keywords

ANTINEOPLASTIC AGENT; DEFENSIN; DOXORUBICIN; MAGAININ DERIVATIVE; MSI 238; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; CANCER CELL; GROWTH REGULATION; HUMAN; HUMAN CELL; INFECTION; INFLAMMATION; INTESTINE CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PHAGOCYTE; PROTEIN LOCALIZATION; PROTEIN SECRETION; REVIEW; SWINE;

EID: 0032428507     PISSN: 02043564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (93)

1. Boman HG. Peptide antibiotics and their role in innate immunity. Ann Rev Immunol 1995; 13: 61-92.
2. Ganz T, Lehrer RI. Antimicrobial peptides of vertebrates. Curr Opin Immunol 1998; 10: 41-4.
3. Hancock RE, Lehrer R. Cationic peptides: a new source of antibiotics. Trends Biotechnol 1998; 16: 82-8.
4. Gazit E, Boman A, Boman HG, Shai Y. Interaction of the mammalian antibacterial peptide cecropin P1 with phospholipid vesicles. Biochemistry 1995; 34: 11479-88.
5. Matsuzaki K, Nakamura A, Murase O, Sugishita K-I, Fujii N, Miyajima K. Modulation of magainin2-lipid bilayer interactions by peptide charge. Biochemistry 1997; 36: 2104-11.
6. Kagan BL, Selsted ME, Ganz T, Lehrer RI. Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. Proc Natl Acad Sci USA 1990; 87: 210-4.
7. Chertov O, Michiel DF, Xu L, Wang JM, Tani K, Murphy WJ, Longo DL, Taub DD, Oppenheim JJ. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem 1996; 271: 2935-40.
8. Yomogida S, Nagaoka I, Yamashita T. Comparative studies on the extracellular release and biological activity of guinea pig neutrophil cationic antibacterial polypeptide of 11 KDa (CAP11) and defensins. Comp Biochem Physiol B Biochem Mol Biol 1997; 116: 99-107.
9. Murphy CJ, Foster BA, Mannis MJ, Selsted ME, Reid TW. Defensins are mitogenic for epithelial cells and fibroblasts. J Cell Physiol 1993; 155: 408-13.
10. Couchman JR, Woods A. Syndecans, signaling, and cell adhesion. J Cell Biochem 1996; 61: 578-84.
11. Gallo RL, Ono M, Povsic T, Page C, Eriksson E, Klagsbrun M, Bernfield M. Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. Proc Natl Acad Sci USA 1994; 91: 11035-9.
12. Pogrebnoy PV, Hobta AI, Garmanchouk LV, Markeeva NV. Inhibition of EGF receptor kinase activity by hydrophobic peptide secreted by A431/1522 cells. Exp Oncol 1997; 19: 296-9 (in Russian).
13. Pogrebnoy PV, Hobta AI, Soldatkina MA, Garmanchouk LV, Markeeva NV, Eremina T. A protein kinase inhibitor from A431 subline overexpressing TGFα possesses antimicrobial activity. New Microbiol 1998; 21: 269-73.
14. Charp PA, Rice WG, Raynor RL, Reimund E, Kinkade JM Jr, Ganz T, Selsted ME, Lehrer RI, Kuo JF. Inhibition of protein kinase C by defensins, antibiotic peptides from human neutrophils. Biochem Pharmacol 1988; 37: 951-6.
15. Lichtenstein A, Ganz T, Selsted ME, Lehrer RI. In vitro tumor cell cytolysis mediated by peptide defensins of human and rabbit granulocytes. Blood 1986; 68: 1407-10.
16. Winder D, Günzburg WH, Erfle V, Salmons B. Expression of antimicrobial peptides has an antitumor effect in human cells. Biochem Biophys Res Commun 1998; 242: 608-12.
17. Lehrer RI, Ganz T. Antimicrobial polypeptides of human neutrophils. Blood 1990; 76: 2169-81.
18. Patterson-Delafield J, Martinez RJ, Lehrer RI. Microbicidal cationic proteins in rabbit alveolar macrophages: a potential host defense mechanism. Infect Immun 1980; 30: 180-92.
19. Selsted ME, Brown DM, DeLange RJ, Harwig SSL, Lehrer RI. Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils. J Biol Chem 1985; 260: 4579-84.
20. Ganz T, Selsted ME, Szklarek D, Harwig SS, Daher K, Bainton DF, Lehrer RI. Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest 1985; 76: 1427-35.
21. Wilde CG, Griffith JE, Marra MN, Snable, JL, Scott RW. Purification and characterization of human neutrophil peptide 4, a novel member of the defensin family. J Biol Chem 1989; 264: 11200-3.
22. Eisenhauer PB, Harwig SS, Szklarek D, Ganz T, Selsted ME, Lehrer RI. Purification and antimicrobial properties of three defensins from rat neutrophils. Infect Immun 1989; 57: 2021-7.
23. Selsted ME, Harwig SS. Purification, primary structure, and antimicrobial activities of a guinea pig neutrophil defensin. Infect Immun 1987; 55: 2281-6.
24. Lambert J, Keppi E, Dismarq J-L, Wicker C, Reichhart J-M, Dunbar B, Lepage P, Van Dorsselaer A, Hoffmann J, Fothergill J, Hoffmann D. Insect immunity: isolation from immune blood of the dipteran Phormia terranovae of two insect antibacterial peptides with sequence homology to rabbit lung macrophage bactericidal peptides. Proc Natl Acad Sci USA 1989; 86: 262-7.
25. Eisenhauer PB, Lehrer RI. Mouse neutrophils lack defensins. Infect Immun 1992; 60: 3446-7.
26. Ouellette AJ, Miller SI, Henschen AH, Selsted ME. Purification and primary structure of mouse cryptdin-1, a Paneth cell defensin. FEBS Lett 1992; 304: 146-8.
27. Ouellette AJ, Greco RM, James M, Frederick D, Naftilan J, Fallon JT. Developmental regulation of cryptdin, a corticostatin/defensin precursor mRNA in mouse small intestinal crypt epithelium. J Cell Biol 1989; 108: 1687-95.
28. Zhu Q, Hu J, Mulay S, Esch F, Shimasaki S, Solomon S. Isolation and structure of corticostatin peptides from rabbit fetal and adult lung. Proc Natl Acad Sci USA 1988; 85: 592-6.
29. Hu J, Bennet HP, Lazure C, Solomon S. Isolation and characterisation of corticostatic peptides from guinea pig bone marrow. Biochem Biophys Res Commun 1991; 180: 558-65.
30. Zanetti M, Del Sal G, Storici P, Schneider C, Romeo D. The cDNA of the neutrophil antibiotic Bac5 predicts a pro-sequence homologous to a cysteine proteinase inhibitor that is common to other neutrophil antibiotics. J Biol Chem 1993; 268: 522-6.
31. Gennaro R, Skerlavaj B, Romeo D. Purification, composition, and activity of two bactenecins, antibacterial peptides of bovine neutrophils. Infect Immun 1989; 57: 3142-6.
32. Frank RW, Gennaro R, Schneider K, Przybylski M, Romeo D. Amino acid sequences of two proline-rich bactenecins. Antimicrobial peptides of bovine neutrophils. J Biol Chem 1990; 265: 18871-4.
33. Selsted M, Novotny MJ, Morris WL, Tang Y-Q, Smith W, Cullor JS. Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. J Biol Chem 1992; 267: 4292-5.
34. Selsted ME, Tang Y-Q, Morris WL, McGuire P, Novotny MJ, Smith W, Henschen AH, Cullor JS. Purification, primary structures, and antibacterial activities of b-defensins, a new family of antimicrobial peptides from bovine neutrophils. J Biol Chem 1993; 268: 6641-8.
35. Zimmermann GR, Legault P, Selsted M, Pardi A. Solution structure of bovine neutrophil β-defensin-12: the peptide fold of the β-defensins is identical to that of the classical defensins. Biochemistry 1995; 34: 13663-71.
36. Diamond G, Zasloff M, Eck H, Brasseur M, Maloy WL, Bevins CL. Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA. Proc Natl Acad Sci USA 1991; 88: 3952-6.
37. Schonwetter BS, Stolzenberg ED, Zasloff M. Epithelial antibiotics induced at sites of inflammation. Science 1995; 267: 1645-8.
38. McCray PB, Bentley L. Human airway epithelia express a beta-defensin. Am J Resp Cell Mol Biol 1997; 16: 343-9.
39. Ko YH, Delannoy M, Pedersen PL. Cystic fibrosis, lung infections, and a human tracheal antimicrobial peptide (hTAP). FEBS Lett 1997; 405: 200-8.
40. Diamond G, Russell JP, Bevins CL. Inducible expression of an antibiotic peptide gene in lipopolysacharide-challenged tracheal epithelial cells. Proc Natl Acad Sci USA 1996; 93: 5156-60.
41. Russell JP, Diamond J, Tarver AP, Scanlin TF, Bevins CL. Coordinate induction of two antibiotic genes in tracheal epithelial cells exposed to the inflammatory mediators lipopolysacharide and tumor necrosis factor alpha. Infect Immun 1996; 64: 1565-8.
42. Stolzenberg ED, Anderson GM, Ackerman MR, Whitlock RH, Zasloff M. Epithelial antibiotic induced in states of disease. Proc Natl Acad Sci USA 1997; 94: 8686-90.
43. Porter EM, van Dam E, Valore EV, Ganz T. Broad-spectrum antimicrobial activity of human intestinal defensin 5. Infect Immun 1997; 65: 2396-401.
44. Lee J-Y, Boman A, Sun C, Andersson M, Jurnvall H, Mutt V, Boman HG. Antibacterial peptides from pig intestine: isolation of a mammalian cecropin. Proc Natl Acad Sci USA 1989; 86: 9159-62.
45. Agerberth B, Lee JY, Bergman T, Carlquist M, Boman HG, Mutt V, Jörnvall H. Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides. Eur J Biochem 1991; 202: 849-54.
46. Agerberth B, Gunne H, Odeberg J, Kogner P, Boman HG, Gudmundsson GH. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc Natl Acad Sci USA 1995; 92: 195-9.
47. Gudmundsson GH, Agerberth B, Odeberg G, Bergman T, Olsson B, Salcedo R. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur J Biochem 1996; 238: 325-32.
48. Frohm M, Agerberth B, Ahangari G, Stahle-BAckdahl M, Liun S, Wigzell H, Gudmundsson GH. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem 1997; 232: 15258-63.
49. Wade D, Boman A, Wehlin B, Drain CM, Andreu D, Boman HG, Merrifield RB. All D-amino acid-containing channel-forming antibiotic peptides. Proc Natl Acad Sci USA 1990; 87: 4761-5.
50. Bessalle R, Kapitkovsky A, Gorea A, Shalit I, Fridkin M. All-D-magainin: chirality, antimicrobial activity and proteolytic resistance. FEBS Lett 1990; 274: 151-5.
51. Hugosson M, Andreu D, Boman HG, Glaser E. Antibacterial peptides and mitochondrial presequences affect mitochondrial coupling, respiration and protein import. Eur J Biochem 1994; 223: 1027-33.
52. Sipos D, Andersson M, Ehrenberg A. The structure of the mammalian peptide cecropin P1 in solution, determined by proton-NMR. Eur J Biochem 1992; 209: 163-9.
53. Durell SR, Raghunathan G, Guy HR. Modeling the ion channel structure of cecropin. Biophys J 1992; 63: 1623-31.
54. Pouny Y, Rapaport D, Mor A, Nicolas P, Shai Y. Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes. Biochemistry 1992; 31: 12416-23.
55. Matsuzaki K, Murase O, Tokuda H, Funakoshi S, Fujii N, Miyajima K. Orientational and aggregational states of magainin 2 in phospholipid bilayers. Biochemistry 1994; 33: 3342-9.
56. Matsuzaki K, Yoneyama S, Fujii N, Miyajima K, Yamada K, Kirino Y, Anzai K. Membrane permeabilization mechanisms of a cyclic antimicrobial peptide, tachyplesin I, and its linear analog. Biochemistry 1997; 36: 9799-806.
57. Lehrer RI, Barton A, Daher KA, Harwig S, Ganz T, Selsted ME. Interaction of human defensins with Escherichia coli - mechanism of bactericidal activity. J Clin Invest 1989; 84: 553-61.
58. Skerlavaj B, Romeo D, Gennaro R. Rapid membrane permeabilization and inhibition of vital functions of gram-negative bacteria by bactenecins. Infect Immun 1990; 58: 3724-30.
59. Fujii G, Selsted ME, Eisenberg D. Defensin promote fusion and lysis of negatively charged membranes. Prot Sci 1993; 2: 1301-12.
60. Boman HG, Agerberth B, Boman A. Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine. Infect Immun 1993; 61: 2978-84.
61. Bateman A, Singh A, Congote LF, Solomon S. The effect of HP-1 and related neutrophil granule peptides on DNA synthesis in HL60 cells. Regul Pept 1991; 35: 135-43.
62. Van Wetering S, Mannesse-Laseroms SP, Dijkman JH, Hiemstra PS. Effect of neutrophil serine proteinases and defensins on lung epithelial cells: modulation of cytotoxicity and IL-8 production. J Leuk Biol 1997; 62: 217-26.
63. Johansson J, Gudmundsson GH, Rottenberg ME, Berndt KD, Agerberth B. Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem 1998; 273: 3718-24.
64. Michaelson D, Rayner J, Couto M, Ganz T. Cationic defensins arise from charge-neutralized propeptides: a mechanism for avoiding leukocyte autocytotoxicity? J Leuk Biol 1992; 51: 634-9.
65. Zanetti M, Litteri L, Griffiths G, Gennaro R, Romeo D. Stimulus-induced maturation of probactenecins, precursors of neutrophil antimicrobial polypeptides. Immunol 1991; 146: 4295-300.
66. Storici P, Zanetti M. A novel cDNA sequence encoding a pig leukocyte antimicrobial peptide with a cathelin-like pro-sequence. Biochem Biophys Res Commun 1993; 196: 1363-8.
67. Ganz T. Extracellular release of antimicrobial defensins by human polymorphonuclear leukocytes. Infect Immun 1987; 55: 568-71.
68. Schluesener H, Meyermann R. Neutrophilic defensins penetrate the blood brain barrier. J Neurosci Res 1995; 42: 718-23.
69. Ouellette AJ. Paneth cells and innate immunity in the crypt microenvironment. Gastroenterol 1997; 113: 1779-84.
70. Bateman A, MacLeod RJ, Lembessis P, Hu J, Esch F, Solomon S. The isolation and characterization of a novel corticostatin/defensin-like peptide from the kidney. J Biol Chem 1996; 271: 10654-9.
71. Verbanac D, Zanetti M, Romeo D. Chemotactic and protease-inhibiting activities of antibiotic peptide precursors. FEBS Lett 1993; 317: 255-8.
72. Territo MC, Ganz T, Selsted ME, Lehrer R. Monocyte-chemotactic activity of defensins from human neutrophils. J Clin Invest 1989; 84: 2017-20.
73. Brandt E, Petersen F, Flad H-D. Recombinant tumor necrosis factor-alpha potentiates neutrophil degranulation in response to host defense cytokines neutrophil-activating peptide 2 and IL-8 by modulating intracellular cyclic AMP levels. J Immunol 1992; 149: 1356-64.
74. Yomogida S, Nagaoka I, Saito K, Yamashita T. Evaluation of the effects of defensins on neutrophil functions. Inflamm Res 1996; 45: 62-7.
75. Ichinose M, Asai M, Imai K, Sawada M. Enhancement of phagocytosis by corticostatin I (CSI) in cultured mouse peritoneal macrophages. Immunopharmacol 1996; 35: 103-9.
76. Misuno NI, Osipovich OA, Sudarikov AB, Idelson GL, Kolesnikova TS, Panyutich AV, Voitenok NN. Tumor necrosis factor alpha induction in human monocytes. Cytokine 1990; 2: 464-9.
77. Murphy CJ, Foster BA, Mannis MJ, Selsted ME, Reid TW. Defensins are mitogenic for epithelial cells and fibroblasts. J Cell Physiol 1993; 155: 408-13.
78. Okrent DG, Lichtenstein AK, Ganz T. Direct cytotoxicity of polymorphonuclear leukocyte granule proteins to human lung-derived cells and endothelial cells. Am Rev Resp Dis 1990; 141: 179-85.
79. Moore AJ, Devine DA, Bibby MC. Preliminary experimental anticancer activity of cecropins. Pept Res 1994; 7: 265-9.
80. Cruciani RA, Barker JL, Zasloff MM, Chen HC, Colamonici O. Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation. Proc Natl Acad Sci USA 1991; 88: 3792-6.
81. Jacob L, Zasloff M. Potential therapeutic applications of magainins and other antimicrobial agents of animal origin. In: Goode J, ed. Ciba Found Symp No 186. Chichester: John Wiley & Sons Ltd, 1994: 197-216, discuss 216-23.
82. Westerhoff HV, Zasloff M, Rosner JL, Hendler RW, De Waal A, Vaz Gomes A, Jongsma PM, Riethorst A, Juretic D. Functional synergism of the magainins PGLa and magainin-2 in Escherichia coli, tumor cells and liposomes. Eur J Biochem 1995; 228: 257-64.
83. Ohsaki Y, Gazdar AF, Chen HC, Johnson BE. Antitumor activity of magainin analogues against human lung cancer cell lines. Cancer Res 1992; 52: 3534-8.
84. Baker MA, Maloy WL, Zasloff M, Jacob LS. Anticancer efficacy of Magainin2 and analogue peptides. Cancer Res 1993; 53: 3052-7.
85. Soballe PW, Maloy WL, Myrga RL, Jacob LS, Herlyn M. Experimental local therapy of human melanoma with lytic magainin peptides. Int J Cancer 1995; 60: 280-4.
86. Haimovich B, Tanaka JC. Magainin-induced cytotoxicity in eukaryotic cells: kinetics, dose-response and channel characteristics. Biochim Biophys Acta 1995; 1240: 149-58.
87. Matsuzaki K, Nakamura A, Murase O, Sugishita K-i, Fujii N, Miyajima K. Modulation of Magainin 2-lipid bilayer interactions by peptide charge. Biochemistry 1997; 36: 2104-11.
88. Shin SY, Lee MK, Kim KL, Hahm KS. Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 2 and cecropin A-melittin hybrid peptides. J Pept Res 1997; 50: 279-85.
89. Pogrebnoy PV, Garmanchouk LV, Markeena NV, Protas APh, Bykorez AI. Peculiarity of influence of melittin and it's triptolytic fragment on activation of protein kinase C. Biopolymers Cell 1996; 12 (3): 41-6 (in Russian).
90. Selsted ME, Harwig SS, Ganz T, Schilling JW, Lehrer RI. Primary structures of three human neutrophil defensins. J Clin Invest 1985; 76: 1427-35.
91. Jones DE, Bevins CL. Paneth cells of the human small intestine express an antimicrobial peptide gene. J Biol Chem 1992; 267: 23216-25.
92. Bensch KW, Raida M, Magert HJ, Schultz-Knappe P, Forssmann WG. hBD-1: a novel beta-defensin from human plasma. FEBS Lett 1995; 368: 331-5.
93. Harder J, Bartels J, Christophers E, Schroder JM. A peptide antibiotic from human skin. Nature 1997; 387: 861.